Rocket Pharmaceuticals
Aaron Ondrey is an experienced finance executive currently serving as the Chief Financial Officer at Rocket Pharmaceuticals since March 2024. Previously, Aaron held the Chief Financial Officer position at Mirati Therapeutics from July 2022 to January 2024, and served in various leadership roles at Arena Pharmaceuticals, Inc., including Vice President of Finance. Aaron's extensive experience includes significant positions at prominent companies such as Alexion Pharmaceuticals, Regeneron Pharmaceuticals, and Jerini Ophthalmic Inc., demonstrating expertise in finance, strategic planning, and business development. Aaron holds a Bachelor of Science in Business Administration and Finance from Case Western Reserve University.
This person is not in any teams
This person is not in any offices